|
RPRD1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.32220000188022E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.47699999972917E-07 |
| Normal-vs-Stage2 |
7.917600E-03 |
| Normal-vs-Stage3 |
3.476000E-03 |
| Normal-vs-Stage4 |
1.519210E-01 |
| Stage1-vs-Stage2 |
7.302200E-01 |
| Stage1-vs-Stage3 |
4.381400E-01 |
| Stage1-vs-Stage4 |
9.314800E-01 |
| Stage2-vs-Stage3 |
3.458600E-01 |
| Stage2-vs-Stage4 |
8.846200E-01 |
| Stage3-vs-Stage4 |
6.176600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.42869999947482E-07 |
| Normal-vs-AfricanAmerican |
1.63739999999857E-05 |
| Normal-vs-Asian |
2.4116000000296E-06 |
| Caucasian-vs-AfricanAmerican |
8.774400E-01 |
| Caucasian-vs-Asian |
1.834970E-01 |
| AfricanAmerican-vs-Asian |
1.031980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.08539999713153E-08 |
| Normal-vs-Female |
1.999510E-03 |
| Male-vs-Female |
1.164960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.203400E-03 |
| Normal-vs-Extreme_Weight |
1.16910000003134E-06 |
| Normal-vs-Obese |
1.375910E-04 |
| Normal-vs-Extreme_Obese |
2.430000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.989800E-01 |
| Normal_Weight-vs-Obese |
7.225400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.026000E-01 |
| Extreme_Weight-vs-Obese |
4.337400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.417600E-01 |
| Obese-vs-Extreme_Obese |
5.394400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.999850E-02 |
| Normal-vs-Age(41-60Yrs) |
8.28680000000137E-05 |
| Normal-vs-Age(61-80Yrs) |
1.90529999999356E-07 |
| Normal-vs-Age(81-100Yrs) |
2.683800000014E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.010000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.541200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.141420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.386400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.225800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.941400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.03370000004155E-06 |
| Normal-VS-Type2 PRCC |
1.80157999999375E-05 |
| Normal-VS-KIRP CIMP |
4.455900E-02 |
| Normal-VS-Unclassified PRCC |
7.760900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.788800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.942200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.120000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.917200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.774000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.943600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.21210000048455E-07 |
| Normal-vs-N1 |
2.000300E-04 |
| Normal-vs-N2 |
3.390000E-01 |
| N0-vs-N1 |
6.076000E-01 |
| N0-vs-N2 |
7.462400E-01 |
| N1-vs-N2 |
6.327800E-01 |
|
|
